By MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks. The company’s filing comes as new infections are rising once again, driven mainly by hot spots […]
